Bausch+Lomb IPO Presentation Deck

Opportunity to gain share in large, growing addressable markets Expand into new categories Invest in fast growing categories Continue momentum in current portfolio Total addressable market B+L Market Share BAUSCH+ LOMB PreserVision. LUMIFY -$50B -7% 2019 they INFUSE Biotrue envistatoric Artelac -$48B -7% 2020 Bio true -$50B ~8% ULTTRE 2021 eyeTELLIGENCE La XIPERE Preseran Opportunity to Accelerate Growth Ocuvile ADULT SO -$53B 2022 ARIS NOV03 Ranibizumab biosimilar ( -$56B 2023 UITHE LLNIFY -$59B 2024 KED FINANCIAL PERFORMANCE ~$62B 88 2025 Preseren AREDS Opportunity to Accelerate Growth 2026+ 42

View entire presentation